GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (STU:NTK1) » Definitions » Short Interest

NetScientific (STU:NTK1) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is NetScientific Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of NetScientific's Short Interest

For the Biotechnology subindustry, NetScientific's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NetScientific's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NetScientific's Short Interest distribution charts can be found below:

* The bar in red indicates where NetScientific's Short Interest falls into.


NetScientific (STU:NTK1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (STU:NTK1) » Definitions » Short Interest
Comparable Companies
LSE:ONC LSE:SNG LSE:BVX LSE:VAL LSE:ROQ AQSE:PBX LSE:BSFA LSE:IMM LSE:OCTP LSE:CIZ OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
NSCI:UK
Address
20 Saint Andrew Street, Holborn Circus, London, GBR, EC4A 3AG
Website
https://www.netscientific.net
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

NetScientific (STU:NTK1) Headlines

No Headlines